Darbepoetin alfa and chronic kidney disease.
Hampl
Hannelore
H
Kovesdy
Csaba P
CP
Kalantar-Zadeh
Kamyar
K
D000740:Anemia / Q000188:drug therapy*; D000068256:Darbepoetin alfa; D004921:Erythropoietin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006397:Hematinics / Q000009:adverse effects / Q000627:therapeutic use*; D006454:Hemoglobins / Q000378:metabolism*; D006801:Humans; D008297:Male; D010976:Platelet Count; D006435:Renal Dialysis; D051436:Renal Insufficiency, Chronic / Q000097:blood* / Q000150:complications; D012306:Risk; D020521:Stroke / Q000139:chemically induced / Q000453:epidemiology
D006397:Hematinics; D006454:Hemoglobins; D004921:Erythropoietin; D000068256:Darbepoetin alfa